| Dr Paul Casinelli, MD | |
|
40 Tupelo Hill Dr, Cranston, RI 02920-3722 | |
| (401) 456-2125 | |
| Not Available |
| Full Name | Dr Paul Casinelli |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Experience | 44 Years |
| Location | 40 Tupelo Hill Dr, Cranston, Rhode Island |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013086552 | NPI | - | NPPES |
| PE05925 | Medicaid | RI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | MD05925 (Rhode Island) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lawrence & Memorial Hospital | New london, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northeast Medical Group Inc | 1254233836 | 1251 |
| Northeast Medical Group Inc | 1254233836 | 1251 |
News Archive
University of Sydney researchers aim to help clear up conflicting dietary advice around egg consumption, as a new study finds eating up to 12 eggs per week for a year did not increase cardiovascular risk factors in people with pre-diabetes and type 2 diabetes.
MMP (USA) announces Worldwide Business with kathy ireland exclusive interview with International Cancer Center. Dr. Eduardo Lovo, Executive Director & Chief of the Brain Radiosurgery Unit of ICC, explains, "We make the treatment of many types of cancer affordable and accessible to many patients who have no other recourse for treatment. By using the most effective and efficient technologies and equipment, we're breaking new ground in making advanced cancer treatment affordable."
Unlike conventional cancer drugs that attack and kill cancer cells directly, anti-cancer immunotherapy, which kills cancer cells by strengthening the body's immunity, is a novel type of cancer treatment currently attracting increased attention. Unfortunately, a minority of cancer patients who have some degree of pre-existing immunity only benefit from anti-cancer immunotherapy.
Merck, known as MSD outside the United States and Canada, today announced that its New Drug Application for an investigational, tablet formulation of the company's antifungal agent, NOXAFIL (posaconazole), has been accepted for review by the U.S. Food and Drug Administration.
Researchers have made predictions as to how the tuberculosis (TB) epidemic in Peru might progress over the next 30 years, depending on what measures are used to fight it.
› Verified 7 days ago
| Entity Name | South County Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790193522 PECOS PAC ID: 2062735053 Enrollment ID: O20141224000069 |
News Archive
University of Sydney researchers aim to help clear up conflicting dietary advice around egg consumption, as a new study finds eating up to 12 eggs per week for a year did not increase cardiovascular risk factors in people with pre-diabetes and type 2 diabetes.
MMP (USA) announces Worldwide Business with kathy ireland exclusive interview with International Cancer Center. Dr. Eduardo Lovo, Executive Director & Chief of the Brain Radiosurgery Unit of ICC, explains, "We make the treatment of many types of cancer affordable and accessible to many patients who have no other recourse for treatment. By using the most effective and efficient technologies and equipment, we're breaking new ground in making advanced cancer treatment affordable."
Unlike conventional cancer drugs that attack and kill cancer cells directly, anti-cancer immunotherapy, which kills cancer cells by strengthening the body's immunity, is a novel type of cancer treatment currently attracting increased attention. Unfortunately, a minority of cancer patients who have some degree of pre-existing immunity only benefit from anti-cancer immunotherapy.
Merck, known as MSD outside the United States and Canada, today announced that its New Drug Application for an investigational, tablet formulation of the company's antifungal agent, NOXAFIL (posaconazole), has been accepted for review by the U.S. Food and Drug Administration.
Researchers have made predictions as to how the tuberculosis (TB) epidemic in Peru might progress over the next 30 years, depending on what measures are used to fight it.
› Verified 7 days ago
| Entity Name | Northeast Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043278351 PECOS PAC ID: 1254233836 Enrollment ID: O20170518000594 |
News Archive
University of Sydney researchers aim to help clear up conflicting dietary advice around egg consumption, as a new study finds eating up to 12 eggs per week for a year did not increase cardiovascular risk factors in people with pre-diabetes and type 2 diabetes.
MMP (USA) announces Worldwide Business with kathy ireland exclusive interview with International Cancer Center. Dr. Eduardo Lovo, Executive Director & Chief of the Brain Radiosurgery Unit of ICC, explains, "We make the treatment of many types of cancer affordable and accessible to many patients who have no other recourse for treatment. By using the most effective and efficient technologies and equipment, we're breaking new ground in making advanced cancer treatment affordable."
Unlike conventional cancer drugs that attack and kill cancer cells directly, anti-cancer immunotherapy, which kills cancer cells by strengthening the body's immunity, is a novel type of cancer treatment currently attracting increased attention. Unfortunately, a minority of cancer patients who have some degree of pre-existing immunity only benefit from anti-cancer immunotherapy.
Merck, known as MSD outside the United States and Canada, today announced that its New Drug Application for an investigational, tablet formulation of the company's antifungal agent, NOXAFIL (posaconazole), has been accepted for review by the U.S. Food and Drug Administration.
Researchers have made predictions as to how the tuberculosis (TB) epidemic in Peru might progress over the next 30 years, depending on what measures are used to fight it.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul Casinelli, MD Po Box 6064, Providence, RI 02904 Ph: () - | Dr Paul Casinelli, MD 40 Tupelo Hill Dr, Cranston, RI 02920-3722 Ph: (401) 456-2125 |
News Archive
University of Sydney researchers aim to help clear up conflicting dietary advice around egg consumption, as a new study finds eating up to 12 eggs per week for a year did not increase cardiovascular risk factors in people with pre-diabetes and type 2 diabetes.
MMP (USA) announces Worldwide Business with kathy ireland exclusive interview with International Cancer Center. Dr. Eduardo Lovo, Executive Director & Chief of the Brain Radiosurgery Unit of ICC, explains, "We make the treatment of many types of cancer affordable and accessible to many patients who have no other recourse for treatment. By using the most effective and efficient technologies and equipment, we're breaking new ground in making advanced cancer treatment affordable."
Unlike conventional cancer drugs that attack and kill cancer cells directly, anti-cancer immunotherapy, which kills cancer cells by strengthening the body's immunity, is a novel type of cancer treatment currently attracting increased attention. Unfortunately, a minority of cancer patients who have some degree of pre-existing immunity only benefit from anti-cancer immunotherapy.
Merck, known as MSD outside the United States and Canada, today announced that its New Drug Application for an investigational, tablet formulation of the company's antifungal agent, NOXAFIL (posaconazole), has been accepted for review by the U.S. Food and Drug Administration.
Researchers have made predictions as to how the tuberculosis (TB) epidemic in Peru might progress over the next 30 years, depending on what measures are used to fight it.
› Verified 7 days ago